IRIS (psychedelic)
This article relies largely or entirely on a single source. (June 2019) |
![]() | |
Names | |
---|---|
Preferred IUPAC name 1-(5-Ethoxy-2-methoxy-4-methylphenyl)propan-2-amine | |
Other names 2-Methoxy-5-ethoxy-4-methylamphetamine 2-Methoxy-5-ethoxy-4-methyl-1-ethyl-(alpha-methyl)amine | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H21NO2 | |
Molar mass | 223.316 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
IRIS (2-methoxy-5-ethoxy-4-methylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the 5-ethoxy analog of DOM. IRIS was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 9 mg, and the duration unknown.[1] IRIS produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IRIS.
See also
[edit]References
[edit]